Department of Emergency Medicine, MedStar Georgetown University Hospital, 3800 Reservoir Rd. NW, Washington, DC, United States of America; Department of Emergency Medicine, MedStar Washington Hospital Center, 110 Irving St. NW, Washington, DC, United States of America.
Department of Emergency Medicine, MedStar Georgetown University Hospital, 3800 Reservoir Rd. NW, Washington, DC, United States of America; Department of Emergency Medicine, MedStar Washington Hospital Center, 110 Irving St. NW, Washington, DC, United States of America.
Am J Emerg Med. 2022 Nov;61:52-55. doi: 10.1016/j.ajem.2022.08.037. Epub 2022 Aug 19.
High sensitivity troponin assays have become widespread for emergency department evaluation of acute chest pain. We assessed if a high sensitivity troponin under the 99th percentile upper reference limit drawn at 6 h or greater from symptom onset could safely rule out acute coronary syndrome in patients who did not meet the rapid rule-out strategy.
We conducted a multicenter retrospective study examining emergency department patients with chest pain who did not meet rapid-rule out criteria and were admitted for further evaluation. Among these admitted patients, we assessed the rate of clinically relevant adverse cardiac events (death, cardiac or respiratory arrest, STEMI, or life-threatening arrhythmia) and NSTEMI in patients with high sensitivity troponin less than the 99th percentile value obtained after at least 6 h of chest pain.
Out of 1187 patients admitted, we found 30 clinically relevant adverse cardiac events, all of which occurred in patients admitted for another compelling reason or ischemic ECG. 36 patients had an NSTEMI, of which 33 were identified with high sensitivity troponin greater than 99th percentile upper reference limit within 6 h of chest pain onset. This left 0 clinically relevant adverse cardiac events and 3 NSTEMI among the 429 patients with high sensitivity troponin less than the 99th percentile at 6 h and nonischemic ECG and no other compelling reason for admission.
This study assessed patients with chest pain with high sensitivity troponin values between 3 ng/L and the 99th percentile upper reference limit after 6 h of chest pain and found that they have a low rate of clinically relevant adverse cardiac events and NSTEMI.
高敏肌钙蛋白检测已广泛应用于急诊科急性胸痛的评估。我们评估了在胸痛发作 6 小时或更长时间后,检测值低于 99 百分位上限的高敏肌钙蛋白是否可安全排除不符合快速排除策略的急性冠状动脉综合征患者。
我们进行了一项多中心回顾性研究,纳入急诊科胸痛且不符合快速排除标准而需要进一步评估的患者。在这些入院患者中,我们评估了在胸痛发作至少 6 小时后,肌钙蛋白检测值低于 99 百分位值的患者中,临床相关不良心脏事件(死亡、心脏或呼吸骤停、ST 段抬高型心肌梗死或威胁生命的心律失常)和非 ST 段抬高型心肌梗死的发生率。
在 1187 名入院患者中,我们发现了 30 例临床相关不良心脏事件,这些事件均发生在因其他强烈入院指征或缺血性心电图而入院的患者中。36 例患者发生了非 ST 段抬高型心肌梗死,其中 33 例在胸痛发作后 6 小时内肌钙蛋白检测值高于 99 百分位上限。在胸痛发作 6 小时后肌钙蛋白检测值低于 99 百分位上限、心电图非缺血且无其他强烈入院指征的 429 例患者中,无临床相关不良心脏事件和 3 例非 ST 段抬高型心肌梗死。
这项研究评估了胸痛患者在胸痛发作 6 小时后肌钙蛋白值在 3ng/L 和 99 百分位上限之间的情况,发现这些患者临床相关不良心脏事件和非 ST 段抬高型心肌梗死的发生率较低。